NeOnc advances brain cancer pipeline toward FDA meeting
NeOnc approaches a regulatory milestone with an upcoming FDA meeting for its brain cancer treatment pipeline.
NeOnc approaches a regulatory milestone with an upcoming FDA meeting for its brain cancer treatment pipeline.